Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Go back to Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption
(NASDAQ: ACON) Delayed: 3.05 +0.01 (0.33%)
Previous Close $3.04    52 Week High
Open $2.97    52 Week Low
Day High $3.05    P/E N/A 
Day Low $2.97    EPS
Volume 7,245       

(NASDAQ: ACONW) Delayed: 0.03 --0 (-0%)
Previous Close $0.03    52 Week High
Open $0.03    52 Week Low
Day High $0.03    P/E N/A 
Day Low $0.03    EPS
Volume 1,412